S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit
DMT1
S-Nitrosylation
Pars compacta
Nitrosylation
DOI:
10.1523/jneurosci.3262-17.2018
Publication Date:
2018-08-13T17:47:55Z
AUTHORS (20)
ABSTRACT
Elevated iron deposition has been reported in Parkinson's disease (PD). However, the route of uptake leading to high substantia nigra is unresolved. Here, we show a mechanism enhanced Fe 2+ via S-nitrosylation divalent metal transporter 1 (DMT1). While DMT1 could be S-nitrosylated by exogenous nitric oxide donors, human PD brains, endogenously was detected postmortem nigra. Patch-clamp electrophysiological recordings and assays confirmed increased Mn or through DMT1. We identified two major sites, C23 C540, mass spectrometry, C23A C540A substitutions abolished (NO)-mediated current increase. To evaluate vivo significance, lipopolysaccharide (LPS) stereotaxically injected into female male mice induce inflammation production NO. The intranigral LPS injection resulted corresponding increase deposition, JNK activation, dopaminergic neuronal loss deficit motoric activity, these were rescued NO synthase inhibitor l -NAME DMT1-selective blocker ebselen. Lentiviral knockdown LPS-induced neuron loss. SIGNIFICANCE STATEMENT Neuroinflammation cytoplasmic levels have implicated initiation progression neurodegenerative diseases. report unexpected enhancement functional activity transmembrane (DMT1) S-nitrosylation. demonstrated that DMT1-mediated uptake, cysteines spectrometry sites for uptake. One conceptual advance while external acidification because gating proton motive, discovered also Significantly, lipopolysaccharide-induced death ameliorated using -NAME, inhibitor, ebselen, blocker.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....